By expenditures
| Name | Title | Type |
|---|---|---|
| Amber Brosius | Audit Partner In Charge | Auditee |
| Christopher Smith | Vice President, Corporate Controller | Auditee |
| Marykate Federico | AUDIT PARTNER | Auditee |
| Michael Lowen | DIRECTOR | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 372193 | 2024 | 2025-11-15 | ERNST & YOUNG LLP | $42.25M |
| 327330 | 2022 | 2024-11-05 | Ernst & Young LLP | $55.39M |
| 327329 | 2023 | 2024-11-05 | Ernst & Young LLP | $15.73M |
| 27876 | 2022 | 2023-09-28 | Ernst & Young LLP | $23.75M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 372193 | 2024 | 2025-11-15 | 1162411 | 2024-001 | Material Weakness | Yes | CJL |
| 372193 | 2024 | 2025-11-15 | 1162410 | 2024-002 | Material Weakness | Yes | E |
| 372193 | 2024 | 2025-11-15 | 1162409 | 2024-001 | Material Weakness | Yes | CJ |
| 327330 | 2022 | 2024-11-05 | 1081163 | 2022-004 | Material Weakness | - | P |
| 327330 | 2022 | 2024-11-05 | 1081162 | 2022-003 | Significant Deficiency | Yes | P |
| 327330 | 2022 | 2024-11-05 | 1081161 | 2022-002 | Material Weakness | - | ABEJ |
| 327330 | 2022 | 2024-11-05 | 1081160 | 2022-001 | Significant Deficiency | Yes | ABL |
| 327329 | 2023 | 2024-11-05 | 1081159 | 2023-003 | Material Weakness | - | I |
| 327329 | 2023 | 2024-11-05 | 1081158 | 2023-002 | Material Weakness | - | CJL |
| 327329 | 2023 | 2024-11-05 | 1081157 | 2023-002 | Material Weakness | - | CJL |
| 327329 | 2023 | 2024-11-05 | 1081156 | 2023-001 | Material Weakness | Yes | E |
| 327330 | 2022 | 2024-11-05 | 504721 | 2022-004 | Material Weakness | - | P |
| 327330 | 2022 | 2024-11-05 | 504720 | 2022-003 | Significant Deficiency | Yes | P |
| 327330 | 2022 | 2024-11-05 | 504719 | 2022-002 | Material Weakness | - | ABEJ |
| 327330 | 2022 | 2024-11-05 | 504718 | 2022-001 | Significant Deficiency | Yes | ABL |
| 327329 | 2023 | 2024-11-05 | 504717 | 2023-003 | Material Weakness | - | I |
| 327329 | 2023 | 2024-11-05 | 504716 | 2023-002 | Material Weakness | - | CJL |
| 327329 | 2023 | 2024-11-05 | 504715 | 2023-002 | Material Weakness | - | CJL |
| 327329 | 2023 | 2024-11-05 | 504714 | 2023-001 | Material Weakness | Yes | E |
| 27876 | 2022 | 2023-09-28 | 608813 | 2022-002 | Material Weakness | - | ABEJ |
| 27876 | 2022 | 2023-09-28 | 608812 | 2022-003 | Significant Deficiency | Yes | P |
| 27876 | 2022 | 2023-09-28 | 608811 | 2022-001 | Significant Deficiency | Yes | ABL |
| 27876 | 2022 | 2023-09-28 | 32371 | 2022-002 | Material Weakness | - | ABEJ |
| 27876 | 2022 | 2023-09-28 | 32370 | 2022-003 | Significant Deficiency | Yes | P |
| 27876 | 2022 | 2023-09-28 | 32369 | 2022-001 | Significant Deficiency | Yes | ABL |